By directly comparing gene expression, other studies found that EphA1 (31), EphA2 (32), and VEGFR-1 (33) were indicators in different stages of ccRCC but lacked large sample support. This evidence concerns the gene EPHA2 and nonpapillary renal cell carcinoma.